Verrica Pharmaceuticals Inc (VRCA)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Verrica Pharmaceuticals Receives FDA*s New Chemical Entity Status for YCANTH
Verrica Pharmaceuticals Teams Up with Walgreens to Revolutionize Distribution of YCANTH Therapy
Deficit on Weak Sales at the VRCA in the second quarter of 2023
The company published Revenue of $8.319 millions, in the most recent fiscal period